Paolo Pedrazzoli

Professor of Oncology

Università degli Studi di Pavia

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Paolo Pedrazzoli is a Professor of Oncology at Università degli Studi di Pavia, Italy. His research focuses on the management of cancer patients, particularly concerning antimicrobial resistance, treatment paradigms for advanced melanoma, and the impact of COVID-19 therapies on cancer care. He has contributed to various studies highlighting patient empowerment in cancer management and the importance of gut microbiota in breast cancer treatment.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

Alberto Malovini

ITALY

View details

Marco Lucioni

Professor

University of Pavia

ITALY

View details

Francesco Fabozzi

Università degli Studi di Roma La Sapienza

ITALY

View details

Mark Bower

Professor

Chelsea and Westminster Hospital

UNITED KINGDOM

View details

Greta Petazzoni

Università degli Studi di Pavia

ITALY

View details

Chandra Bortolotto

ITALY

View details

Juan Aguilar-Company

Vall d´Hebron Institut d´Oncologia

SPAIN

View details

LUCIA SACCHI

Associate Professor

University of Pavia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paolo Pedrazzoli

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of View

Current Treatment Paradigms for Advanced Melanoma with Brain Metastases

Real-World Experience with the Available Outpatient COVID-19 THErapies in Patients with canceR (CO.THER)

Phase I Clinical Trial on Pleural Mesothelioma Using Neoadjuvant Local Administration of Paclitaxel-Loaded Mesenchymal Stromal Cells (PACLIMES Trial): Study Rationale and Design

Spermatocytic Tumor: A Review

Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up

Long-COVID in Patients with Cancer Previously Treated with Early Anti-SARS-CoV-2 Therapies in an Out-of-Hospital Setting: A Single-Center Experience

The Key Role of Patient Empowerment in the Future Management of Cancer-Related Malnutrition

The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study

Management of Nutritional Needs in Pediatric Oncology: A Consensus Statement

Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry

A Nutritional Approach for the Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer

Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study

Cost-effectiveness analysis of oral nutritional supplements with nutritional counselling in head and neck cancer patients undergoing radiotherapy

Collaborators (8)

Alberto Malovini

Marco Lucioni

Francesco Fabozzi

Mark Bower

Greta Petazzoni

Chandra Bortolotto

Juan Aguilar-Company

LUCIA SACCHI

Make your next move.